In partnership with
January 14, 2026
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition is brought to you by Wispr Flow and beehiiv. We break down the strategic move behind HR 7010, where a bipartisan coalition is attempting to desynchronize the industry’s "compliance cliff" from the biological reality of the 2026 planting season. From the collision of the new Medicare pilot program with federal THC caps to Texas’s attempt at an administrative shutdown through 13,000% fee hikes, we analyze the procedural tools regulators are using to reshape the market. We also dive into the high-stakes coordinated campaign to repeal legalization in the Northeast and the new legal theories targeting herbal additives in edibles.
🚜 The 2026 Planting Window
🌵 Texas De Facto Ban
🚫 Coordinated Repeal Offensive
Farms can’t wait for floor votes.
Stop Planning. Start Building.
End of the year? Or time to start something new.
With beehiiv, this quiet stretch of time can become your biggest advantage. Their platform gives you all the tools you need to make real progress, real fast.
In just days (or even minutes) you can:
Build a fully-functioning website with the AI website builder
Launch a professional-looking newsletter
Earn money on autopilot with the beehiiv ad network
Host all of your content on one easy-to-use platform
If you’re looking to have a breakthrough year, beehiiv is the place to start. And to help motivate you even more, we’re giving you 30% off for three months with code BIG30.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Representative Jim Baird (R-IN) and a heavyweight bipartisan group, including House Oversight Chair James Comer (R-KY), House Agriculture Ranking Member Angie Craig (D-MN), and North Carolina Speaker-turned-Congressman Tim Moore (R-NC), formally introduced HR 7010 (the Hemp Planting Predictability Act) on January 12. The bill targets the compliance cliff created by the November 2025 shutdown Appropriations Act that established an aggressive 0.4mg per-package total THC cap. By extending the implementation deadline from one year to three, HR 7010 pauses the ban until November 2028. This move responds to intense pressure from agricultural and wellness interests who argue that without immediate relief, the 2026 planting season is dead on arrival.
💡 Why It Matters: The urgency here is driven by a collision between the biological reality of farming and a significant shift in White House policy. Farmers are finalizing planting contracts for 2026 right now. They cannot risk capital on a crop that could be reclassified as contraband before harvest. Simultaneously, President Trump’s December 18th Executive Order (EO 14370) has changed the math. That order directs the CMS to launch a Medicare pilot program for full-spectrum CBD products. If the 0.4mg cap remains, the very therapeutic oils the President wants for seniors and veterans would technically become Schedule I narcotics. This policy friction, where one federal agency is banning what another is attempting to reimburse, provides the necessary leverage for Republican leadership to revisit a law passed just months ago.
🧠 THC Group Take: HR 7010 is a critical survival maneuver for the hemp-derived beverage and wellness sectors. It attempts to sync the industry’s timeline with the new "medical-first" narrative coming from the White House. By pushing the deadline to 2028, the bill creates a roughly 34-month window for the CMS pilot to generate real clinical data. This data could eventually justify a permanent, science-based THC threshold rather than an arbitrary cap.
However, we should not assume this specific bill will become law. It is one of several competing proposals, including Senator Ron Wyden’s more comprehensive effort to build a federal regulatory framework from the ground up. The true value of HR 7010 is as an exercise in political acumen and industry maturation. It serves as a vehicle to demonstrate to a Congress, many of whom have never seen or tried a hemp beverage, that the market is real and the consumer demand is legitimate. By championing this legislation, operators are effectively demonstrating that they are not asking for a lack of oversight, but for responsible, workable rules. This is an opening bid in a winding process. The industry must use this window to prove it is ready for regular order by institutionalizing professional standards in age-gating and labeling, moving the conversation away from prohibition and toward permanent, professionalized regulation.
Fast-moving headlines, flagged for what matters.
The Texas Department of State Health Services has unveiled draft rules that would dismantle the state’s $5.5 billion hemp market by including THCA in total THC calculations. This redefinition effectively bans smokable hemp flower and numerous derivative products that comprise the bulk of current retail sales. Beyond the chemical threshold, the proposal introduces a massive increase in licensing fees, raising annual retailer registrations from $150 to $20,000 per location. The strategy forces a consolidation of the state’s 9,100 hemp businesses, clearing a path for the three heavily restricted medical cannabis licensees to capture the resulting vacuum. With an implementation date as early as January 25th, businesses face an immediate liquidity crisis and the prospect of total inventory obsolescence. (MJBizDaily)
Prohibitionists have launched a high-stakes coordinated attack targeting the 2026 ballot in Massachusetts, Maine, and Arizona to repeal regulated adult-use markets. These near-identical initiatives seek to end legal sales and, in some jurisdictions, re-criminalize non-medical home cultivation. The effort reflects a tactical shift as experienced political operatives leverage a recent fifteen-point collapse in Republican support for legalization to build well-funded repeal campaigns. This is the first large-scale attempt to prove that cannabis legalization is politically reversible through the same ballot process that created it. Organizers expect to spend upwards of $20 million per state, forcing the industry into an expensive defensive posture. A successful repeal in any state would dismantle the "one-way street" assumption of reform and spike the risk premium on cannabis assets nationwide. (Marijuana Moment)
Nineteen states, including several with robust legal markets, have joined the Trump administration in urging the Supreme Court to uphold a federal ban on firearm possession by cannabis consumers. The amicus brief argues that 18 U.S.C. § 922(g)(3) remains a constitutional exercise of federal power despite recent appellate court rulings citing the Second Amendment’s historical tradition test. By supporting the disarmament of "unlawful drug users," these legal-market states are prioritizing federal drug classifications over their own residents' state-level rights. This alignment demonstrates that state governments remain willing to maintain prohibitionist penalties when they intersect with broader firearm regulations. It reinforces the persistent "second-class" legal status of cannabis consumers and suggests that rescheduling alone may not resolve complex cross-sector regulatory frictions. (Creators.com)
New lawsuits tied to 1906 Midnight Drops are steering causation toward the product’s herbal add-ins rather than THC, reinforcing concerns regulators have signaled for years. Colorado, Massachusetts, and state health agencies previously warned that Corydalis and Stephania extracts in certain batches were associated with liver injury indicators. The legal theory matters because it reframes product safety risk around formulation choices that sit outside the cannabinoid debate and standard cannabis testing panels. This creates a tighter environment for brands regarding substantiation, supplier qualification, and adverse event response, especially for products marketed for sleep or wellness. Enforcement and liability pressure will likely follow any edible or capsule that utilizes exotic botanicals without a defensible safety record and a clean documentation trail.. (Law.com)
The New Jersey Legislature has passed a sweeping reform bill that simultaneously empowers law enforcement and dilutes the Governor's control over the Cannabis Regulatory Commission (CRC). By classifying unlicensed shops as public nuisances and granting State Police specific seizure authority, the state is moving to protect the valuation of its legal license holders from the legacy shadow market. Crucially, the bill restructures the CRC with an elected chair and allows local officials to serve as commissioners, a move aimed at breaking the administrative gridlock that has slowed retail rollouts. A new expansion provision allowing a single flagship to support two satellite locations offers a rare path to scale in a historically restrictive environment. (Heady NJ)
Ohio Attorney General Dave Yost rejected a petition summary intended to repeal the new law that banned intoxicating hemp and added new criminal penalties for marijuana usage. The rejection letter cited several examples of misleading information, including an incorrect claim that the bill repealed prohibitions on license holders offering free product samples. Advocates with Ohioans for Cannabis Choice described the setback as a temporary speed bump and signaled their intent to fix the language and resubmit the petition immediately. The friction highlights the disconnect between current legislative measures and the 57% of Ohioans who voted to legalize recreational cannabis in 2023. The decision creates a strategic delay for industry advocates while ensuring that the state's new enforcement measures remain unchallenged through the current operational cycle. (News 5 Cleveland)
Florida’s Secretary of State is moving to dismiss a lawsuit from the Smart & Safe Florida campaign over 71,000 invalidated petition signatures, heightening the risk for the 2026 recreational ballot. The state’s argument - that inactive voters and out-of-state gatherers invalidate tens of thousands of petitions - threatens the campaign’s ability to meet the critical February 1st certification deadline. This is a test of how "voter integrity" frameworks can be weaponized to stall high-momentum market entries. A ruling against the campaign would spike costs in the final weeks of the window and signal a hardening state stance against industry expansion despite overwhelming public support. (South Florida Sun-Sentinel)
The federal circuit court split over the Dormant Commerce Clause is creating an unstable landscape for state-level residency requirements. Recent rulings suggest that state-mandated local ownership rules are increasingly vulnerable to constitutional challenges despite the federal illegality of cannabis. If the judiciary continues to invalidate these protectionist barriers, current fragmented state markets will face rapid consolidation through out-of-state capital. This legal shift forces regulators to choose between defending local mandates or preparing for an inevitable transition to interstate trade. Enterprises currently sheltered by residency caps should expect increased competition as legal pathways for national investment firms expand. (Harris Sliwoski Canna Law Blog)
IRS scrutiny of cannabis financial records is intensifying as federal auditors refine their understanding of Section 280E nuances. Most operational failures currently stem from undocumented labor allocations and overhead calculations that lack measurable production drivers. While seed-to-sale software satisfies state tracking requirements, these systems rarely produce the granular accounting data necessary to survive a federal tax examination. Relying on manual spreadsheets or informal percentage assumptions creates a significant liability during the standard three-year look-back window. Consistent inventory reconciliation and formal costing policies are now baseline requirements for maintaining enterprise value. (Cannabis Industry Journal)
The acquisition of BellRock Brands by KEY Investment Partners marks a strategic pivot for heritage names Dixie Elixirs and Mary’s Medicinals. Now operating under the MM Brands banner and led by former Curaleaf CEO Joe Bayern, the portfolio is shedding the heavy, vertically integrated baggage that led to its receivership in favor of a lean, IP-focused distribution model across 11 states. This illustrates a broader trend among first-mover brands forced to decouple high-cost cultivation and retail assets from their core consumer intellectual property. The new ownership is betting that professionalized management of specialized categoriess, pecifically beverages and medical-grade transdermals, will provide a more sustainable path to profitability. (Cannabis Equipment News)
Effective January 1st, Maine has officially eliminated excise taxes on adult-use cannabis sales and transfers between licensed cultivation facilities and product manufacturing facilities. This legislative shift is designed to reduce financial friction within the state's supply chain by removing tax burdens on internal wholesale transactions. The broader tax reform package also includes a significant reduction in weight-based excise tax rates for flower, trim, and plants sold to other licensees. While these wholesale changes aim to lower operational costs for businesses, the state simultaneously increased the retail sales tax on adult-use products from 10 percent to 14 percent. This structural realignment reflects a strategic attempt to support industry liquidity while increasing revenue at the point of final sale. (Law360)
The New Jersey CRC signaled a shift toward stricter operational oversight this week by voting unanimously to deny the license renewal for Mad Hatter Dispensary. Unlike previous high-profile disputes with multi-state operators that resulted in immediate settlements, this denial stems from a fundamental breakdown in local relations and administrative compliance. By citing the loss of municipal approval and the failure to file required social equity reports after a cure period, the commission is establishing a zero-tolerance precedent for administrative negligence. This move warns licensees that initial approval is no longer a guarantee of permanent market access, particularly as regulators face pressure to professionalize the sector. (Heady NJ)
California is formalizing the transition of cannabis from craft mystery to industrial commodity through a $1.2 million research partnership between UC Berkeley and Glass House Brands. This state-funded project aims to replace anecdotal tribal knowledge with verifiable baseline data on how genetics and environment dictate crop yields. By standardizing these metrics, the state is building the foundation for the sophisticated tax, insurance, and lending models that have historically excluded cannabis due to unpredictable production cycles. The long-term consequence is an increase in agricultural efficiency that will eventually favor large-scale, low-cost producers ready for national commodity trade. (Cannabis Business Times)
German medical cannabis prescriptions have surged by 3,300% following the plant’s removal from the narcotics list, but this volume has come at the cost of a 40% collapse in the price per gram. While regulators are attempting to use the "telemedicine misuse" narrative to justify new restrictions, the data suggests this growth is a legitimate migration from the illicit market. This tension between market efficiency and conservative oversight creates a risk of policy whiplash in Europe’s largest market. If regulators over-correct through restrictive rulemaking, they risk eroding the public health gains achieved by liberalized access, effectively handing the market back to unlicensed channels. (High Times)
The closure of The Medicine Woman’s 5,000-square-foot Jersey City facility after just six months highlights the high mortality rate of hype-driven retail footprints. Despite a launch backed by Ice-T and Taylor Kinney, the business collapsed under the weight of unpaid rent, taxes, and security liens totaling over $110,000. Ownership’s pivot to blaming regulatory infrastructure underscores a common pitfall: assuming celebrity capital can substitute for the rigorous municipal compliance and lean operational overhead required in the Northeast. This failure serves as a cautionary tale for investors; celebrity attachment provides a floor for initial awareness, but it does not provide a ceiling for the compounding costs of local regulatory friction. (Jersey Digs)
New polling shows 60% of Indiana residents support adult-use legalization, yet legislative leadership remains resistant even as a bipartisan slate of reform bills is filed for the 2026 session. As a final holdout in a Midwest region that has fully legalized, Indiana is experiencing significant revenue leakage to neighboring states. The tension between voter demand and legislative inaction is transforming cannabis into a primary-season wedge issue where incumbents face increasing pressure from pro-reform challengers. For regional operators, Indiana remains the last frontier of the Midwest, representing significant untapped value if federal rescheduling finally forces the state's hand. (Marijuana Moment)
Voice-first code workflows with auto file tagging and variable recognition. Dictate reproductions and prompts and paste clean, code-friendly text into GitHub, Jira, or your editor. Try Wispr Flow for engineers.
From the hearing room to the comment section — we’re watching it all.
🧬 Mapping the enzymatic pathways of cannabinoid production provides the technical foundation needed to distinguish botanical compounds from synthetic analogs in a regulatory setting. This biological clarity allows policymakers to move beyond arbitrary weight-based limits toward standards based on how a plant actually grows. Establishing these origins is essential for protecting lawful hemp supply chains from the spillover effects of bans targeting laboratory-synthesized molecules. (Vice)
🎤 Phillip Sweet of Little Big Town received an absolute discharge in a Cayman Islands court after customs officers found 11 medicinal cannabis gummies in his luggage. Although the magistrate accepted a physician's letter and Sweet's belief that the low THC content was legal, the case highlights the lack of international reciprocity for U.S. hemp standards. This outcome serves as a strategic warning for traveling executives that federal compliance under the Farm Bill does not provide a safe harbor at international borders. (Cayman Compass)